Glycoproteomics-based identification of cancer biomarkers.
about
Glycoproteomic and glycomic databasesElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsProtein-centric N-glycoproteomics analysis of membrane and plasma membrane proteinsGlycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes.Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.Novel Citronellyl-Based Photoprobes Designed to Identify ER Proteins Interacting with Dolichyl Phosphate in Yeast and Mammalian Cells.Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancerThe Cosmc connection to the Tn antigen in cancer.Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.Glycomic expression in esophageal disease.Coupling enrichment methods with proteomics for understanding and treating disease.Intact glycopeptide characterization using mass spectrometry.Can glycoprofiling be helpful in detecting prostate cancer?Application of post-genomic techniques in dog cancer research.Chemical Glycoproteomics.Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell LinesAssessment of Hepatocellular Carcinoma Metastasis Glycobiomarkers Using Advanced Quantitative N-glycoproteome Analysis.Evaluation of glycophenotype in prostatic neoplasm by chemiluminescent assay.Insights into the binding specificity of wild type and mutated wheat germ agglutinin towards Neu5Acα(2-3)Gal: a study by in silico mutations and molecular dynamics simulations.Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.Sweet characterisation of prostate specific antigen using electrochemical lectin-based immunosensor assay and MALDI TOF/TOF analysis: Focus on sialic acid.Glycosylation Changes in Brain Cancer.Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma.
P2860
Q21245406-624C6A44-3891-4DE4-B26A-7CA6E4924838Q26822552-62930F89-2416-4282-9BEE-E9E858D8777FQ27009121-0121A1CB-B905-47BE-B96E-1D4B422711EBQ30382105-BD44A448-AFBB-41A8-A329-C1F75A9B93D0Q34804402-CB9630A0-9EEE-44A2-8009-158BE829EB31Q36263057-C7376805-5757-4AD7-A0BC-9CE6D9236A33Q36807623-2B65AF89-909B-426F-83D4-5851EB63788BQ36945404-77BFF17E-D74F-49A9-813C-E31A0201EA6EQ37130046-FFC9A0FA-11A4-4E51-8E21-5AD4A1088C61Q37565619-0F461A0A-24DE-4C4E-8410-6769FAE8884BQ38197051-AF88F463-9FA0-4740-9ECC-B96BBF166F04Q38215756-73FA5C97-0928-41D8-83A6-5FCDAEE617D1Q38222621-7C0CC72E-616E-424A-A5D4-2DCA178E7705Q38293824-3D6373FC-AD3B-42B4-BCD3-117068D22562Q38824113-60B85773-E63E-44BF-A230-CA5120D15910Q38852467-78B7FDDC-BE6A-4D06-9395-06D78197D6ADQ38877571-1D08A118-65CE-4D3F-A7EB-E1D733DEBF20Q39037656-ED666E20-A815-4C21-9BDB-BECE5797EE84Q39559313-C08788F0-9C7B-485C-9497-94A449A2E532Q40955052-8440C92F-F25F-4B55-9B9C-9D14134124ACQ42782962-0CAF6EE4-00F2-4953-A23F-065AB1E9E28BQ44306984-8E6590B2-8D0E-4622-85CA-44B418314F7AQ46091778-399902EC-F567-4542-B268-8BA864DBB7D6Q47139131-F0EA5DCF-1BCD-4CAD-8FB9-C9A721FD90A2Q47691736-8495C5F6-CA31-4FC7-850B-5C77B682510DQ49335113-DD4215B2-465D-4BD8-A257-F40116C05494
P2860
Glycoproteomics-based identification of cancer biomarkers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Glycoproteomics-based identification of cancer biomarkers.
@en
type
label
Glycoproteomics-based identification of cancer biomarkers.
@en
prefLabel
Glycoproteomics-based identification of cancer biomarkers.
@en
P2860
P356
P1476
Glycoproteomics-based identification of cancer biomarkers.
@en
P2093
David E Misek
Evelyn H Kim
P2860
P304
P356
10.1155/2011/601937
P577
2011-09-28T00:00:00Z